PNC Financial Services Group
HBIO icon

PNC Financial Services Group’s Harvard Bioscience HBIO Stock Holding History

PNC Financial Services Group’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86 Hold
14
– – ﹤0.01% 5157
2026
Q1 		$68 Hold
14
– – ﹤0.01% 5111
2025
Q4 		$96 Sell
14
-740
-98% -$4.39K ﹤0.01% 5055
2025
Q3 		$3.31K Hold
754
– – ﹤0.01% 4356
2025
Q2 		$3.35K Sell
754
-38
-5% -$159 ﹤0.01% 4257
2025
Q1 		$4.48K Buy
792
+274
+53% +$3.51K ﹤0.01% 4103
2024
Q4 		$10.9K Buy
518
+513
+10,260% +$11.8K ﹤0.01% 3773
2024
Q3 		$145 Hold
5
– – ﹤0.01% 4702
2024
Q2 		$154 Buy
+5
New +$175 ﹤0.01% 4696
2024
Q1 		– Sell
-2
Closed -$118 – 4741
2023
Q4 		$118 Buy
+2
New +$90 ﹤0.01% 4511
2018
Q3 		– Sell
-15
Closed -$1K – 4169
2018
Q2 		$1K Sell
15
-339
-96% -$17.4K ﹤0.01% 4057
2018
Q1 		$18K Hold
354
– – ﹤0.01% 3484
2017
Q4 		$12K Hold
354
– – ﹤0.01% 3622
2017
Q3 		$13K Buy
+354
New +$10.5K ﹤0.01% 3579
2014
Q4 		– Sell
-40
Closed -$2K – 4190
2014
Q3 		$2K Buy
+40
New +$1.84K ﹤0.01% 3661

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $118M AUM
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
CCM
Corsair Capital Management New York $800M AUM 94.38% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PNC Financial Services Group's HBIO Position: Q2 2026 in Review

PNC Financial Services Group held its Harvard Bioscience (HBIO) position steady in Q2 2026 at 14 shares worth $86. The position accounts for ﹤0.01% of the portfolio, ranked #5157.

PNC Financial Services Group first reported a position in HBIO in Q3 2014 and has held it in 15 quarters since. The position peaked at $18K in Q1 2018. 37 funds tracked by Wall St. Rank hold HBIO as of Q2 2026.

  • PNC Financial Services Group held 14 shares of Harvard Bioscience worth $86 as of Q2 2026.
  • PNC Financial Services Group left its Harvard Bioscience share count unchanged in Q2 2026.
  • Harvard Bioscience made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5157 holding.
  • PNC Financial Services Group first reported a position in Harvard Bioscience in Q3 2014 and has held it in 15 quarters since.
  • PNC Financial Services Group's Harvard Bioscience position peaked at $18K in Q1 2018.
  • 37 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.